Member Info for Noshortsallowed

Expecting a TR1 RNS stating Polygon have increased their holding. If not the shares have been mopped up non the less.

Huge ascending triangle what's not to like?!

https://www.bioindustry.org/news-listing/transcrip-announces-landmark-investment-from-palatine-private-equity.html

bioindustry.org/news-listing/transcrip-announces-landmark-investment-from-palatine-private-equity.html

Every time we see a code 1 we know who is topping up lol. Thanks PMJH and all the best in your endeavours.

'Golden Cross'

Most P3's are 60% successful but Numis is giving SNG's P3 a 70% chance of being successful.

I think Zwart forgot to say he multiplied the £40 per share value by the P/E ratio of 2.5 which gives him his £100 a share lol.

If we break through 120 then we're looking at new 52 week highs with positive news.

Hands are firmly in the pockets. Just wish I could've topped up over the last few weeks.

An RNS could very well land in the morning which would be great!
I was just thinking that it could follow the same pattern as the phase II first patient dosed RNS which landed on the Tuesday.

There could very well be an RNS in the morning which would be great!
I'm just thinking that the RNS could land Tuesday morning as it did for the first patient being dosed in the phase II trial.

In anticipation of a Phase III first patient dosed RNS 0700 Tuesday morning. Will we see FOMO kick in on Monday?
If so, I feel we will break through some resistances and enter us into a bull run.

Phase III trials are about to commence imminently (fingers and toes crossed) in Europe, North and South America and India but nowhere in the Far East or Africa. I thought we wanted to get a good data set from as broad a spectrum of ethnic groups as possible? Or are we just targeting countries where SNG are most likely to get EUA'S?